Spinal Surgery
Bleeding during spine surgery can significantly impair a surgeon’s visual field and lead to increased operating room time. Baxter's portfolio of haemostat, sealants and tissue repair products aims to reduce bleeding and aims to increase access by supporting teams who improve patient mobility and quality of life.
Each spine procedure provides unique challenges that can cause complications for the healing process. Here are a few examples.
Anterior Cervical Discectomy and Fusion (ACDF)
In ACDF surgeries, haemostats minimise blood loss and help to ease surgical complexities. FLOSEAL, Baxter's flowable haemostat, provides effective, quick haemostasis (90 seconds median time to haemostasis)1 to improve visibility and overall outcomes2.
Posterolateral Spinal Fusion (PLF)
During this common spine procedure, surgical teams rely on haemostats and orthobiologics to manage blood loss and promote bone growth. INDUCTIGRAFT, Baxter's bioactive bone graft substitute, offers enhanced porosity and performance to achieve optimal fusion rates3,4,5*.
*Preclinical data. Results may not correlate to performance in humans
Learn more about INDUCTIGRAFT >
Transforaminal Interbody Fusion (TLIF)
In another common spine surgery, Baxter's bone haemostasis material, OSTENE, provides immediate bone haemostasis. This water-soluble polymer does not require removal and dissolves within 48 hours. It can be used on all bleeding bone surfaces, including areas where bone fusion is critical6,7,8,9*.
*Preclinical data. Results may not correlate to performance in humans
Portfolio of Products
Prescribing Information:
 |
Ireland TISSEEL |
Suspected Adverse Reactions and any drug product quality complaints (including suspected defective medicines) should be reported to the Health Products Regulatory Authority (HPRA) using a Yellow Card obtained from the HPRA, via the online system (www.hpra.ie) or by telephone on 01-6764971.
Adverse Events relating to Baxter products can also be reported direct to Baxter Pharmacovigilance on +44 1635 206360, or by email to [email protected]
Any drug product quality complaints relating to Baxter products can be reported directly to the Baxter Country Quality Assurance Team on 01 2065500, or by email to [email protected]. Alternatively please report directly to your Baxter Representative, who will take the details and forward to the Baxter Country Quality Assurance Team.